What Is the Treatment of Typhoid Fever When the Organism Is Extensively Drug Resistant?

This protocol addresses uncomplicated enteric fever in which the infecting organism is extensively drug resistant (XDR) — a resistance pattern that renders most standard antibiotic options ineffective and demands a specific, evidence-based management approach.

Clinical Scenario

Uncomplicated enteric fever with a confirmed or suspected XDR infecting organism. The pathogen is resistant to all of the following agents:

Chloramphenicol
Amoxicillin
Cotrimoxazole
Ciprofloxacin
Ceftriaxone

Treatment Approach

Treatment options for uncomplicated XDR enteric fever are limited. The structured protocol identifies the specific oral antibiotic agent that retains activity against XDR strains, along with precise dosing guidance.

Full regimen, dosing schedule, and clinical guidance available in the complete protocol.

Instant Access to Structured Evidence-Based Regimens

References

Treatment options for extensively drug-resistant enteric fever are limited to azithromycin (for uncomplicated disease) and meropenem (for severe disease).

Extensively drug resistant: resistant to chloramphenicol, amoxicillin, cotrimoxazole, ciprofloxacin and ceftriaxone.

View source ↗